XENE XENON PHARMACEUTICALS INC Management Changes 8-K Filing 2025 - Appointments On June 4, 2025, Xenon Pharmaceuticals Inc. held its Annual Meeting, where key board members were elected and the compensation for executives was approved, with 94.10% of shares voting. Proposals included electing 8 directors and appointing PricewaterhouseCoopers as auditors, all receiving strong support from shareholders.Get access to all SEC 8-K filings of the XENON PHARMACEUTICALS INC